We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.94B
AUM Growth
+$1.21B
Cap. Flow
+$1.03B
Cap. Flow %
14.89%
Top 10 Hldgs %
53.97%
Holding
274
New
81
Increased
95
Reduced
45
Closed
48

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$73.4M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$72M
3
JNJ icon
Johnson & Johnson
JNJ
+$64.2M
4
CL icon
Colgate-Palmolive
CL
+$62.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$52.1M

Top Sells

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$73.1M
2
FRPT icon
Freshpet
FRPT
+$58.3M
3
PARA
Paramount Global Class B
PARA
+$48M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$43.7M
5
KYNB
Kyntra Bio
KYNB
+$32.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Consumer Staples 5.26%
3 Consumer Discretionary 4.88%
4 Technology 4.62%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
51
Voyager Therapeutics
VYGR
$192M
$27.2M 0.39%
3,524,000
+128,000
+4% +$1.02M
TMO icon
52
Thermo Fisher Scientific
TMO
$213B
$24.2M 0.35%
42,000
+14,000
+50% +$7.89M
YUM icon
53
Yum! Brands
YUM
$41.3B
$23.9M 0.34%
181,000
+26,000
+17% +$3.35M
SPB icon
54
Spectrum Brands
SPB
$2.08B
$23.5M 0.34%
355,000
+35,000
+11% +$2.21M
HAS icon
55
Hasbro
HAS
$12.9B
$23.5M 0.34%
+437,500
New +$25M
XNCR icon
56
Xencor
XNCR
$1.52B
$23.3M 0.34%
+836,000
New +$25.8M
HZNP
57
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$22.7M 0.33%
+208,000
New +$23M
RIGL icon
58
Rigel Pharmaceuticals
RIGL
$760M
$22.5M 0.32%
1,702,400
+6,800
+0.4% +$108K
LOW icon
59
Lowe's Companies
LOW
$123B
$22.3M 0.32%
111,729
+51,729
+86% +$10.5M
ERAS icon
60
Erasca
ERAS
$6.57B
$22.1M 0.32%
7,350,000
+4,650,000
+172% +$16.9M
FHN icon
61
First Horizon
FHN
$12.4B
$22M 0.32%
+1,236,000
New +$27.5M
ROST icon
62
Ross Stores
ROST
$81.6B
$21.2M 0.31%
200,000
+25,000
+14% +$2.81M
FL
63
DELISTED
Foot Locker
FL
$19.8M 0.29%
500,000
+365,000
+270% +$15.3M
ENR icon
64
Energizer
ENR
$1.51B
$19.4M 0.28%
560,000
-264,000
-32% -$9.35M
WDAY icon
65
Workday
WDAY
$40.8B
$19M 0.27%
92,000
+47,000
+104% +$8.55M
DDOG icon
66
Datadog
DDOG
$83B
$18.9M 0.27%
260,000
+64,000
+33% +$4.7M
DECK icon
67
Deckers Outdoor
DECK
$13.6B
$18.7M 0.27%
249,756
+99,756
+67% +$6.97M
IMCR icon
68
Immunocore
IMCR
$1.73B
$18.7M 0.27%
378,000
+42,000
+13% +$2.36M
LULU icon
69
lululemon athletica
LULU
$14.2B
$18.2M 0.26%
50,000
+20,000
+67% +$6.27M
AUTL
70
Autolus Therapeutics
AUTL
$535M
$17.8M 0.26%
9,672,000
-552,000
-5% -$1.08M
TSN icon
71
Tyson Foods
TSN
$20.4B
$17.7M 0.25%
+298,000
New +$18.3M
BKSY icon
72
BlackSky Technology
BKSY
$1.11B
$16.7M 0.24%
+1,392,835
New +$18.8M
CMG icon
73
Chipotle Mexican Grill
CMG
$42.6B
$15.7M 0.23%
460,000
+310,000
+207% +$9.74M
BCYC
74
Bicycle Therapeutics
BCYC
$279M
$15.7M 0.23%
+736,000
New +$18.5M
ADBE icon
75
Adobe
ADBE
$101B
$15.4M 0.22%
40,000
-38,000
-49% -$13.5M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Armistice Capital held 274 positions worth $6.94B, up 21% from $5.73B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $1.03B of net new capital in Q1 2023, opening 81 new positions and adding to 95 existing holdings. Its largest new stake was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Freshpet, an estimated $58.3M trimmed.

  • Armistice Capital's largest Q1 2023 buy was DICE Therapeutics, Inc. Common Stock: 1,376,000 shares worth $39.4M.
  • Armistice Capital added most to UnitedHealth in Q1 2023, an estimated $73.4M increase.
  • Armistice Capital's biggest Q1 2023 reduction was Freshpet, cutting an estimated $58.3M.
  • Armistice Capital fully exited Pacira BioSciences in Q1 2023, selling an estimated $73.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.94B portfolio in Q1 2023.
  • Armistice Capital opened 81 new positions and closed 48 in Q1 2023.
  • Armistice Capital's portfolio value rose 21% quarter-over-quarter to $6.94B.

Based on Armistice Capital's 13F filing for Q1 2023, filed 15 May 2023.